Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infection.

1 Ohta Y, Ohta N, Tamura M, et al. Vascular endothelial growth factor expression in airways of patients with lung cancer: a possible diagnostic tool of responsive angiogenic status on the host side. Chest 2002; 121:1624–1627 2 Brock CS, Lee SM. Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer. Eur Respir J 2002; 19:557–570 3 Herbst RS, Hidalgo M, Pierson AS, et al. Angiogenesis inhibitors in clinical development for lung cancer. Semin Oncol 2002; 29(suppl):66–77 4 Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347:645–650 5 Kawahito Y, Kondo M, Tsubouchi Y, et al. 15-deoxy12, 14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000; 106:189 –197 6 Inoue K, Kawahito Y, Tsubouchi Y, et al. Expression of peroxisome proliferator-activated receptor in renal cell carcinoma and growth inhibition by its agonists. Biochem Biophys Res Commun 2001; 287:727–732 7 Tsubouchi Y, Sano H, Kawahito Y, et al. Inhibition of human lung cancer cell growth by the peroxisome proliferatoractivated receptoragonists through induction of apoptosis. Biochem Biophys Res Commun 2000; 270:400–405 8 Inoue K, Kawahito Y, Tsubouchi Y, et al. Expression of peroxisome proliferator-activated receptor (PPAR)in human lung cancer. Anticancer Res 2001; 21:2471–2476 9 Xin X, Yang S, Kowalski J, et al. Peroxisome proliferatoractivated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem 1999; 274: 91116–91121 10 Sano H, Hla T, Maier JAM, et al. In vitro cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. Clin Invest 1992; 89:97–108